Praxis Precision Medicines reports positive trial results for epilepsy drug

Go back to Praxis Precision Medicines reports positive trial results for epilepsy drug
(NASDAQ: PRAX) Delayed: 247.09 +6.43 (2.67%)
Previous Close $240.66    52 Week High
Open $241.01    52 Week Low
Day High $247.86    P/E N/A 
Day Low $239.41    EPS
Volume 107,557